Back
Guidewire Software, Inc. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Buy
57
GWRE
Guidewire Software, Inc.
Last Price:
$197.48
Seasonality Move:
5.27%
Sell
38
VKTX
Viking Therapeutics, Inc.
Last Price:
$33.96
Seasonality Move:
33.2%
Buy
57
Guidewire Software, Inc. (GWRE)
is a Buy
Is Guidewire Software, Inc. a Buy, Sell or Hold?
-
The current Guidewire Software, Inc. [GWRE] share price is $197.46. The Score for GWRE is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
GWRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $33.95. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GWRE Stock Price Chart
What is Guidewire Software, Inc.'s stock price today?
-
The Guidewire Software, Inc. share price today is $197.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GWRE is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $33.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
GWRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.27 | Sell |
| Relative Strength Index (14 RSI): | 36.01 | Sell |
| Chaikin Money Flow: | 373485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (200.32 - 217) | Sell |
| Bollinger Bands (100): | (208.87 - 242.63) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.82 | Buy |
| Relative Strength Index (14 RSI): | 40.78 | Sell |
| Chaikin Money Flow: | -1768548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.73 - 38.07) | Sell |
| Bollinger Bands (100): | (27.49 - 37.83) | Buy |
GWRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 198.34 | Sell |
| 20-day SMA: | 206.54 | Sell |
| 50-day SMA: | 222.85 | Sell |
| 200-day SMA: | 218.8 | Sell |
| 8-day EMA: | 198.92 | Sell |
| 20-day EMA: | 205.73 | Sell |
| 50-day EMA: | 216.36 | Sell |
| 200-day EMA: | 215.21 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.15 | Sell |
| 20-day SMA: | 35.99 | Sell |
| 50-day SMA: | 35.96 | Sell |
| 200-day SMA: | 30.15 | Buy |
| 8-day EMA: | 13.47 | Buy |
| 20-day EMA: | 6.19 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 0.68 | Buy |
Guidewire Software, Inc. Earnings Growth & GWRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.10 per share, an increase this year of $1.12 per share, and an increase next year of $0.57 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Guidewire Software, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||